1
|
Bouguergour C, Peyron F, Curti C, Baillié N, Gallice S. [Overview of hospital city repay for paediatric preparations initiated within the Marseille Public University Hospital system]. Ann Pharm Fr 2024; 82:553-559. [PMID: 38387835 DOI: 10.1016/j.pharma.2024.02.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2023] [Revised: 02/09/2024] [Accepted: 02/12/2024] [Indexed: 02/24/2024]
Abstract
OBJECTIVES Hospital internal-use pharmacies are required to make pharmaceutical preparations in order to obtain a medication in a dosage and/or Galenic form (FG) suitable for pediatric use. The aim of this study is to assess the procedures for continuing pharmaceutical preparations initiated within the Assistance Publique des Hôpitaux de Marseille in an outpatient setting. METHODS Hospital discharge prescriptions and/or consultation prescriptions involving paediatric magistral preparations and issued by our Hospital Centre were collected from two pharmacies with significant preparation activity at national level. An analysis of regulatory compliance was carried out, as well as a comparison of the formulation of preparations made in the outpatient setting and in the hospital. RESULTS Au total, 45 prescriptions were collected, representing 52 preparation lines. The regulatory analysis revealed that all the prescriptions contained at least one non-conformity, 60.8% of which related to drug treatments. The prepared FG differed in the outpatient setting compared to the hospital in 46.2% of cases, and in 56% of cases, the vehicle and concentration of the active ingredient used differed when the FG was a liquid oral form. CONCLUSIONS The lack of clear and complete hospital prescriptions makes it difficult to carry out treatment initiated in hospital in the outpatient setting. The multiplicity of information systems between hospitals and outpatient settings are obstacles to the interoperability needed to coordinate patient treatment, particularly in paediatrics. The quality of discharge prescriptions needs to be improved to optimise the patient care pathway.
Collapse
Affiliation(s)
| | - Florence Peyron
- Service pharmacie, CHU Nord, chemin des Bourrely, 13015 Marseille, France
| | - Christophe Curti
- Service de la qualité et de l'information pharmaceutiques (SCQIP), CHU Conception, 147, boulevard Baille, 13005 Marseille, France
| | - Nathalie Baillié
- Pharmacie et préparatoire FRANCEPREP, 180, rue Rabelais, 13016 Marseille, France
| | - Sébastien Gallice
- Pharmacie des Rosiers, 106, boulevard Charles-Moretti, 13014 Marseille, France
| |
Collapse
|
2
|
Curti C, Gallice S, Lamy E, Rathelot P, Vanelle P. [City-hospital network and quality control of officinal preparations]. Ann Pharm Fr 2017; 76:242-247. [PMID: 29037451 DOI: 10.1016/j.pharma.2017.09.003] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2017] [Revised: 09/05/2017] [Accepted: 09/17/2017] [Indexed: 10/18/2022]
Abstract
OBJECTIVES In a hospital environment, the quality control of the hospital preparations allows to release homogeneous batches in a secure way. These controls are totally integrated into the process of production and can also, in certain cases, be realized for high-alert magistral preparations. In community pharmacy, these controls were not required, but the Agence régionale de santé (ARS) recently incited compounding community pharmacies to realize this type of analyses. This decision motivated the creation of a collaboration between the pharmacy department of a French teaching hospital and a society including around thirty community pharmacies having a preparatory. METHODS Twenty community pharmacies distributed on all the territory have submitted one of their pediatric preparation, capsules of captopril 2mg, to the pharmacopoeia controls usually realized in the industry or hospital. RESULTS All the analyzed batches were in agreement with European Pharmacopeia specifications. CONCLUSIONS We shall present the rational of this work, the results as well as the numerous perspectives offered by this new type of collaboration joining completely the logic of a network city-hospital allowing the improvement of security of the medication circuit in France.
Collapse
Affiliation(s)
- C Curti
- Service central de la qualité et de l'information pharmaceutiques, AP-HM, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France; CNRS, UMR 7273, laboratoire de pharmaco-chimie radicalaire, faculté de pharmacie, institut de chimie radicalaire ICR, Aix-Marseille université, 27, boulevard Jean-Moulin, CS 30064, 13385 Marseille cedex 05, France
| | - S Gallice
- Pharmacie des Rosiers, 106, boulevard Charles-Moretti, 13014 Marseille, France
| | - E Lamy
- Service central de la qualité et de l'information pharmaceutiques, AP-HM, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France; Laboratoire de biochimie, faculté de pharmacie, Aix-Marseille université, 27, boulevard Jean-Moulin, CS30064, 13385 Marseille cedex 05, France
| | - P Rathelot
- Service central de la qualité et de l'information pharmaceutiques, AP-HM, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France; CNRS, UMR 7273, laboratoire de pharmaco-chimie radicalaire, faculté de pharmacie, institut de chimie radicalaire ICR, Aix-Marseille université, 27, boulevard Jean-Moulin, CS 30064, 13385 Marseille cedex 05, France
| | - P Vanelle
- Service central de la qualité et de l'information pharmaceutiques, AP-HM, hôpital de la Conception, 147, boulevard Baille, 13005 Marseille, France; CNRS, UMR 7273, laboratoire de pharmaco-chimie radicalaire, faculté de pharmacie, institut de chimie radicalaire ICR, Aix-Marseille université, 27, boulevard Jean-Moulin, CS 30064, 13385 Marseille cedex 05, France.
| |
Collapse
|